News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

Francis deSouza joined Illumina in 2013 as president.
By Christine Farr, Fast Company | 04.27.2016
Untitled Document

A simple blood test to detect early signs of cancer. A noninvasive way to screen pregnancies for common...

By Sharon Begley, STAT | 04.27.2016
Untitled Document

Molecule by molecule, the transformational genome-editing technology called CRISPR-Cas9 is getting so many upgrades so quickly it’s like...

By Ella Morton, Atlas Obscura | 04.26.2016
Untitled Document

On August 17, 1920, the Topeka Daily Capital reported an exciting development: a new class of competition had been added...

By Oliver Holmes, The Guardian [US] | 04.26.2016
Untitled Document

A same-sex couple have won a legal battle in Thailand against the surrogate mother who gave birth to...

By Sarah Zhang, WIRED | 04.25.2016
Untitled Document

In a world with porous borders and wildly divergent surrogacy laws, making a baby can be a global...

By Joseph Stramondo, International Journal of Feminist Approaches to Bioethics Blog | 04.25.2016
Untitled Document

According to a recent article in the popular press, a California based biotech firm, BioMarin Pharmaceuticals, has...

Elizabeth Parrish, CEO, BioViva USA Inc.
By Kerry Grens, The Scientist | 04.25.2016
Untitled Document

Last year, Elizabeth Parrish, the CEO of Seattle-based biotech firm BioViva, hopped a plane to Colombia, where she...

By Jonathan Latham, Independent Science News | 04.25.2016
Untitled Document

For the benefit of those parts of the world where public acceptance of biotechnology is incomplete, a public...